 Astrotech Corporation NASDAQ: ASTC today announced that the BreathTest-1000TM is under development to screen for volatile organic compound VOC metabolites found in a persons breath that could indicate they may have an infection, including Coronavirus Disease 2019 COVID-19 or the resulting disease, pneumonia. The Company believes that its unique mass spectrometry technology that was initially developed in collaboration with the National Aeronautics and Space Administration NASA, the U.S. Army, and the Transportation Security Administration TSA is ideal for lung disease testing applications, which are now under development. 